tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Swedish Orphan Biovitrum’s Phase 3 Study on Pacritinib: A Potential Game-Changer for Myelofibrosis Treatment
Company AnnouncementsSwedish Orphan Biovitrum’s Phase 3 Study on Pacritinib: A Potential Game-Changer for Myelofibrosis Treatment
22h ago
0MTD
Swedish Orphan Biovitrum’s PAXIS Study: A Potential Breakthrough for VEXAS Syndrome
PremiumCompany Announcements
Swedish Orphan Biovitrum’s PAXIS Study: A Potential Breakthrough for VEXAS Syndrome
23h ago
0MTD
Swedish Orphan Biovitrum’s New Study on Hemophilia A Treatment: A Potential Game Changer?
PremiumCompany Announcements
Swedish Orphan Biovitrum’s New Study on Hemophilia A Treatment: A Potential Game Changer?
23h ago
0MTD
Swedish Orphan Biovitrum Advances Haemophilia A Treatment with Ongoing Study
PremiumCompany Announcements
Swedish Orphan Biovitrum Advances Haemophilia A Treatment with Ongoing Study
24h ago
0MTD
Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
PremiumCompany Announcements
Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
1d ago
0MTD
Swedish Orphan Biovitrum’s New Study on Still’s Disease: Market Implications and Insights
PremiumCompany AnnouncementsSwedish Orphan Biovitrum’s New Study on Still’s Disease: Market Implications and Insights
1d ago
0MTD
Swedish Orphan Biovitrum’s New Study on Anakinra: A Potential Game-Changer for FMF Treatment
Premium
Company Announcements
Swedish Orphan Biovitrum’s New Study on Anakinra: A Potential Game-Changer for FMF Treatment
1d ago
0MTD
IQVIA and Swedish Orphan Biovitrum’s PNH Study: A Potential Game-Changer for Pegcetacoplan
Premium
Company Announcements
IQVIA and Swedish Orphan Biovitrum’s PNH Study: A Potential Game-Changer for Pegcetacoplan
1d ago
IQV
Swedish Orphan Biovitrum’s Promising Study on Efanesoctocog Alfa for Haemophilia A
PremiumCompany Announcements
Swedish Orphan Biovitrum’s Promising Study on Efanesoctocog Alfa for Haemophilia A
1d ago
0MTD
Swedish Orphan Biovitrum’s Nitisinone Study: A Closer Look at HT-1 Treatment Outcomes
PremiumCompany Announcements
Swedish Orphan Biovitrum’s Nitisinone Study: A Closer Look at HT-1 Treatment Outcomes
1d ago
0MTD
Helena Saxon Resigns from Sobi Board of Directors
PremiumCompany Announcements
Helena Saxon Resigns from Sobi Board of Directors
7d ago
Sobi Reports Strong Q3 2025 Growth and Strategic Portfolio Expansion
PremiumCompany Announcements
Sobi Reports Strong Q3 2025 Growth and Strategic Portfolio Expansion
9d ago
Sobi Revises 2025 Outlook Following Strong Q3 Performance
PremiumCompany AnnouncementsSobi Revises 2025 Outlook Following Strong Q3 Performance
9d ago
Sobi Increases Common Shares and Votes
Premium
Company Announcements
Sobi Increases Common Shares and Votes
29d ago
Sobi Announces Increase in Shares and Votes to Support Long-term Incentive Programs
Premium
Company Announcements
Sobi Announces Increase in Shares and Votes to Support Long-term Incentive Programs
2M ago
Sobi Completes Class C Share Issuance and Repurchase
PremiumCompany Announcements
Sobi Completes Class C Share Issuance and Repurchase
2M ago
Sobi Reports Strong Q2 2025 Growth and Pipeline Progress
PremiumCompany Announcements
Sobi Reports Strong Q2 2025 Growth and Pipeline Progress
3M ago
Sobi Board Approves Share Repurchase for Incentive Program
PremiumCompany Announcements
Sobi Board Approves Share Repurchase for Incentive Program
4M ago
0MTD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
0MTD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Sobi and Apellis Amend Royalty Agreement for Aspaveli
PremiumCompany AnnouncementsSobi and Apellis Amend Royalty Agreement for Aspaveli
4M ago
Sobi’s Gamifant Receives FDA Approval for Treating MAS in Still’s Disease
Premium
Company Announcements
Sobi’s Gamifant Receives FDA Approval for Treating MAS in Still’s Disease
4M ago
Sobi AGM Approves Key Resolutions and Growth Initiatives
Premium
Company Announcements
Sobi AGM Approves Key Resolutions and Growth Initiatives
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >